Pharmaceutical Commerce Container Special: Unlocking the Cold Chain

The pre-approval pertains to a solid oral dose product that the CDMO will manufacture for a global pharmaceutical company.

Mark Bouck discusses PharmAlliance’s latest acquisitions, while reiterating its goals surrounding health economics and outcomes research.

The latest news for pharma industry insiders.

Chip Davis recaps the organization’s Distribution Management Conference and addresses distributors’ preparedness for DSCSA implementation.

The parties will continue to create new candidate therapies for the treatment of a severe form of TUBB4A leukodystrophy.

The latest news for pharma industry insiders.